Dexilant 30 mg & 60 mg Modified-release capsules, hard
PDF Leaflet Revision Date: 22 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and maintenance of erosive reflux oesophagitis and symptomatic GORD.
Dosage (summary)
Adults: 60 mg once daily for 4 weeks; Maintenance: 30 mg once daily for up to 6 months.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use during pregnancy is not recommended; unknown if excreted in breast milk.
Key Drug Interactions
- HIV protease inhibitors
- Methotrexate
- Digoxin
Contraindications
- Hypersensitivity to dexlansoprazole
- Co-administration with rilpivirine-containing products
Common side effects
- Diarrhoea
- Abdominal pain
- Headache
- Nausea
Counselling Points
- Take capsules whole with liquid
- Monitor for severe allergic reactions
- Consider magnesium levels with prolonged use
Serious warnings
- Risk of acute tubulointerstitial nephritis
- May mask gastric malignancy
- Risk of hypomagnesaemia
Important Disclaimer
The Dexilant 30 mg & 60 mg Modified-release capsules, hard professional information leaflet below is the property of Takeda and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
